Analysis of the drug formulary and the purchasing process at a Moroccan university medical center
- 31 May 2018
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 18 (4) , 415-421
Abstract
Aim: To give an overview of the pharmaceutical policy in the largest medical center in Morocco, a developing country in socio-economic transition. Methods: This is an analytical descriptive study of the drug formulary and the purchasing process carried out at the Ibn Sina University Medical Center. Results: Our formulary included 830 drugs belonging to 14 classes according to the Anatomical, Therapeutic and Chemical (ATC) Classification System. There was a respective predominance of class N (21.8%), class B (13.5%), and class J (12.6%). Injectable route was dominant (46%). Drugs had a significant actual benefit in 70% (according to the French Data), reimbursable in 42.8%, essential in 29.2% according to World Health Organization (WHO) list, and in 36.9% according to the Moroccan list. The calls for tenders included 542 drugs representing 65% of the formulary, and the attribution rate was 71%. The main reason for non-attribution was the lack of offers. Generics accounted for 45% by volume and 26.5% by value. Conclusion: With this first study, we were able to identify key indicators on drugs used in the largest medical center in Morocco. The current challenge is to introduce pharmacoeconomics in decision making concerning the updates of the drug formulary.Keywords
Funding Information
- not funded
This publication has 16 references indexed in Scilit:
- iATC-mHyb: a hybrid multi-label classifier for predicting the classification of anatomical therapeutic chemicalsOncotarget, 2017
- Use of and barriers to access to opioid analgesics: a worldwide, regional, and national studyThe Lancet, 2016
- Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa?Global Health Action, 2014
- Changes in trends and pattern of strong opioid prescribing in primary careEuropean journal of pain, 2014
- Opioid Consumption before and after the establishment of A Palliative Medicine Unit in An Egyptian Cancer CentreJournal of Palliative Care, 2012
- The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi ArabiaSaudi Pharmaceutical Journal, 2010
- Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation‐wide survey of structure, activities, and drug selection proceduresBritish Journal of Clinical Pharmacology, 1999
- The Application of Adverse Drug Reaction Data to Drug Choice Decisions Made by Pharmacy and Therapeutics CommitteesDrug Safety, 1998
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Pharmacoeconomics and Formulary Decision MakingPharmacoEconomics, 1996